BRAND-NEW-GALAXY
17.2.2021 07:02:05 CET | Business Wire | Press release
The rapidly growing global marketing and technology company, Brand New Galaxy launches their Western European Operation in Amsterdam, The Netherlands. The group’s mission is to provide highly specialized and data optimized solutions in E-commerce, Creative & Content Production, and Automation & Performance Improvement from the Dutch capital. Award-winning global marketing and advertising leader, Frank Carvalho is driving the growth of the new operation as Managing Director.
“Our mission is growth. We are growing rapidly, because we are built to drive performance via highly specialized and data optimized solutions for our clients. We deliver growth by utilizing our unique digital offerings and our global network of companies specialized in E-commerce, Creative & Content Production, and Automation & Performance Improvement. We set up our new office in Amsterdam, because the Dutch capital is growing too, becoming the new commercial hub of Europe,” says Frank Carvalho, Managing Director, Brand New Galaxy Amsterdam.
The award-winning Brand New Galaxy is a global provider of end-to-end E-commerce solutions and content production. The company offers several unique methodologies, including Robonauts Pictures E-commerce Real Feel, using production twists that makes online consumers’ product experience comparable to a physical one. Another specialized solution is their FMCC - Fast Moving Consumer Communications method that delivers a quick and scalable content production solution. Part of Brand New Galaxy’s proprietary tools is Synthrone, a modular and flexible ecosystem of automated services for content storage, creation, localization, publishing, tracking, and reporting.
“Efficient management of the entire digital ecosystem is a priority for all businesses who are looking for ways to drive their solid growth in E-commerce. Therefore, as an end-to-end E-commerce player founded on global-to-local methodology we see closer cooperation with our customers in Western Europe as a must have. Our Amsterdam office is a natural consequence of building convenient hubs for well-developed clients and those who are at the early stage of their E-commerce journey,” says Michał Glapiński, Chief Growth Officer responsible for international operations of Brand New Galaxy.
Galactic Growth
Brand New Galaxy has been growing rapidly in the last couple of years by opening new offices and acquiring new companies. Just in 2020 the group launched three offices on three continents, including the United States, the Middle East and Europe. Last year their workforce increased by almost 35 percent to more than 500 employees, with 80 percent of the professionals are working on global and regional levels. They supply global and local services to over 200 clients in 29 languages, from Fortune 500 companies to E-commerce players from small-to-medium-sized businesses. Brand New Galaxy is a three-time winner of the prestigious Press Magazine Awards.
Galactic Talent
Brand New Galaxy’s new Western European operation has a truly global leader. Frank Carvalho, Managing Director has more than 25 years of experience in marketing and advertising from all over the World, including the United States, the United Kingdom, Germany, Poland, Hungary and Australia. He is moving to Amsterdam from New York City, where he was the leader of Account Management in North America and a Global Businesses Director at Hogarth, part of WPP. Some other highlights of his multi-decade career include spending 15 years with the Publicis Groupe as Regional Client Services Director and European Business Lead on Samsung; and being the Senior Brand and Marketing Director at Vodafone in Czech Republic. He has extensive experience in the financial, professional services, pharmaceutical, tobacco, automotive, telecommunications and media sector. He is the winner of four Cannes Lions Awards.
About Brand New Galaxy
Brand New Galaxy is a fast-growing, independent holding of marketing and technology agencies. The privately-owned “independent marketing platform” was founded in Warsaw, Poland in 2017 and has grown to 500+ employees to date. Brand New Galaxy invests in innovative and dynamic ideas that thrive in a start-up environment and are scalable to compete with network agencies. Brand New Galaxy is a member of the MDC Global Affiliates program. Named “Debut of the Year 2018”, “Success of the Year 2019”, “Success of the Year 2020” BNG scores first places in a prestigious agency ranking by PRESS magazine.
Brand New Galaxy companies include:
Pathfinder 23 – global E-commerce agency; Life on Mars – beauty & fashion production agency; Spacecamp – global digital agency; Synthrone - E-commerce automation and implementation platform; Voyager - E-business delivery agency; New Gravity - software & direct-to- consumer house; Robonauts Pictures - E-commerce production house; content26 - Amazon content & advertising, Man on the Moon - HR Agency; BNG MEA – Dubai based hub driving commerce in MEA region; Brand New Galaxy AMS – Amsterdam based hub igniting growth for businesses in Western Europe.
More information:
Web: ams.brandnewgalaxy.com
Downloads: BNG AMS MEDIA
View source version on businesswire.com: https://www.businesswire.com/news/home/20210216006090/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom